Dexamethasone Recruiting Phase 3 Trials for Ropivacaine (DB00296)

IndicationStatusPhase
DBCOND0050586 (Dexamethasone)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03688269Minimal Effective Concentration (EC90) of RopivacaineTreatment